These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2483337)

  • 1. Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressin.
    Woll PJ; Rozengurt E
    Growth Factors; 1988; 1(1):75-83. PubMed ID: 2483337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A substance P antagonist also inhibits specific binding and mitogenic effects of vasopressin and bombesin-related peptides in Swiss 3T3 cells.
    Zachary I; Rozengurt E
    Biochem Biophys Res Commun; 1986 May; 137(1):135-41. PubMed ID: 2424443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells.
    Woll PJ; Coy DH; Rozengurt E
    Biochem Biophys Res Commun; 1988 Aug; 155(1):359-65. PubMed ID: 2843183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic desensitization to bombesin by progressive down-regulation of bombesin receptors in Swiss 3T3 cells. Distinction from acute desensitization.
    Millar JB; Rozengurt E
    J Biol Chem; 1990 Jul; 265(20):12052-8. PubMed ID: 2164025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P-related antagonists inhibit vasopressin and bombesin but not 5'-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells.
    Seckl MJ; Newman RH; Freemont PS; Rozengurt E
    J Cell Physiol; 1995 Apr; 163(1):87-95. PubMed ID: 7534771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
    Patel KV; Schrey MP
    J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer.
    Woll PJ; Rozengurt E
    Br J Cancer; 1988 Jun; 57(6):579-86. PubMed ID: 2841962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
    Woll PJ; Rozengurt E
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
    Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
    Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells.
    Seckl MJ; Higgins T; Rozengurt E
    J Biol Chem; 1996 Nov; 271(46):29453-60. PubMed ID: 8910612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
    Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
    J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization.
    Millar JB; Rozengurt E
    J Biol Chem; 1990 Nov; 265(32):19973-9. PubMed ID: 2174059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity.
    Coy DH; Heinz-Erian P; Jiang NY; Sasaki Y; Taylor J; Moreau JP; Wolfrey WT; Gardner JD; Jensen RT
    J Biol Chem; 1988 Apr; 263(11):5056-60. PubMed ID: 2451661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
    Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
    J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells.
    Severi C; Coy DH; Jensen RT; Boschero L; Anania MC; Delle Fave G
    J Pharmacol Exp Ther; 1989 Nov; 251(2):713-7. PubMed ID: 2478696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S; Spindel ER; Rubin NH; Singh P
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analogue of substance P with broad receptor antagonist activity.
    Zhang L; Mantey S; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1988 Oct; 972(1):37-44. PubMed ID: 2460143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
    Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
    Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-Tyr,D-Arg[Hyp3,D-Phe7,Leu8]BK, a radiolabelled B2 antagonist specifically interacts with two distinct binding sites on epithelial membranes of guinea pig ileum.
    Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
    Agents Actions Suppl; 1992; 38 ( Pt 1)():526-39. PubMed ID: 1334630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.